Cargando…
Risk of COVID-19 Infection After Full Immunization in Patients With Inflammatory Bowel Disease on Treatment: A Research Network Analysis
Background: Acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an issue in treating patients with Inflammatory Bowel Disease (IBD) due to concerns for infection risk and poor post-vaccination antibody response. We examined the potential impact of IBD treatments on SARS-CoV-2 infection rates af...
Autores principales: | Tomanguillo, Julton, Searls, Lauren, Annie, Frank H, Kemper, Suzanne, Naravadi, Vishnu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939048/ https://www.ncbi.nlm.nih.gov/pubmed/36811056 http://dx.doi.org/10.7759/cureus.34004 |
Ejemplares similares
-
Outcomes of Hospitalized Patients With Fecal Occult Positive Stool Prior to Cardiac Catheterization in Acute Coronary Syndrome (ACS)
por: Searls, Lauren, et al.
Publicado: (2023) -
Sa1050: COVID-19 VACCINATION RATES AND POST-VACCINATION INFECTION RISK IN IBD PATIENTS TREATED WITH DISEASE MODIFYING AGENTS: A RESEARCH NETWORK ANALYSIS
por: Chumbe, Julton Tomanguillo, et al.
Publicado: (2022) -
Acute Pancreatitis Due to COVID-19 Active Infection
por: Annie, Frank H, et al.
Publicado: (2021) -
Daptomycin-Induced Acute Liver Failure: A Rare Case Report
por: Rajamanuri, Medha, et al.
Publicado: (2023) -
Emergent Management of Clostridium difficle Infection in a Patient With Chronic Inflammatory Bowel Disease
por: Pomerantz, Lauren H, et al.
Publicado: (2021)